Total Payments
$837,856
2024 Payments
$187,524
Companies
39
Transactions
1,098
Medicare Patients
1,135
Medicare Billing
$183,615
Payment Breakdown by Category
Other$460,528 (55.0%)
Travel$188,229 (22.5%)
Consulting$149,237 (17.8%)
Food & Beverage$26,422 (3.2%)
Research$9,209 (1.1%)
Education$4,197 (0.5%)
Gifts$34.34 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $346,224 | 117 | 41.3% |
| Travel and Lodging | $188,229 | 393 | 22.5% |
| Consulting Fee | $149,237 | 52 | 17.8% |
| Honoraria | $114,304 | 37 | 13.6% |
| Food and Beverage | $26,422 | 487 | 3.2% |
| Unspecified | $9,209 | 2 | 1.1% |
| Education | $4,197 | 9 | 0.5% |
| Gift | $34.34 | 1 | 0.0% |
Payments by Type
General
$828,647
1,096 transactions
Research
$9,209
2 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Davol Inc. | $293,905 | 267 | $0 (2024) |
| TESARO, Inc. | $208,362 | 305 | $0 (2019) |
| GlaxoSmithKline, LLC. | $149,452 | 102 | $0 (2024) |
| Clovis Oncology, Inc. | $80,931 | 88 | $0 (2022) |
| Seagen Inc. | $24,462 | 26 | $0 (2023) |
| Genmab U.S., Inc. | $21,572 | 23 | $0 (2024) |
| Intuitive Surgical, Inc. | $12,999 | 48 | $0 (2023) |
| Eli Lilly and Company | $9,925 | 5 | $0 (2018) |
| Medical Device Business Services, Inc. | $9,506 | 15 | $0 (2022) |
| Myriad Genetic Laboratories, Inc. | $9,227 | 17 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $187,524 | 203 | Davol Inc. ($146,146) |
| 2023 | $208,839 | 199 | Davol Inc. ($99,933) |
| 2022 | $95,976 | 118 | Davol Inc. ($39,136) |
| 2021 | $25,528 | 46 | Medical Device Business Services, Inc. ($8,046) |
| 2020 | $12,936 | 40 | Davol Inc. ($5,250) |
| 2019 | $132,255 | 202 | TESARO, Inc. ($94,522) |
| 2018 | $129,290 | 190 | TESARO, Inc. ($74,789) |
| 2017 | $45,509 | 100 | TESARO, Inc. ($39,050) |
All Payment Transactions
1,098 individual payment records from CMS Open Payments — Page 1 of 44
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Davol Inc. | ARISTA AH FlexiTip (Device) | Travel and Lodging | In-kind items and services | $340.68 | General |
| Category: Surgery | ||||||
| 12/23/2024 | Davol Inc. | ARISTA AH FlexiTip (Device) | Travel and Lodging | In-kind items and services | $295.05 | General |
| Category: Surgery | ||||||
| 12/19/2024 | Davol Inc. | ARISTA AH FlexiTip (Device) | Travel and Lodging | In-kind items and services | $227.88 | General |
| Category: Surgery | ||||||
| 12/18/2024 | Davol Inc. | — | Travel and Lodging | In-kind items and services | $817.67 | General |
| 12/18/2024 | Davol Inc. | — | Travel and Lodging | In-kind items and services | $510.86 | General |
| 12/18/2024 | Davol Inc. | — | Food and Beverage | In-kind items and services | $38.88 | General |
| 12/16/2024 | Davol Inc. | — | Honoraria | Cash or cash equivalent | $5,000.00 | General |
| 12/15/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological), ZEJULA | Food and Beverage | In-kind items and services | $13.35 | General |
| Category: ONCOLOGY | ||||||
| 12/13/2024 | Davol Inc. | ARISTA AH FlexiTip (Device) | Travel and Lodging | In-kind items and services | $35.15 | General |
| Category: Surgery | ||||||
| 12/12/2024 | Davol Inc. | ARISTA AH FlexiTip (Device) | Travel and Lodging | In-kind items and services | $1,168.35 | General |
| Category: Surgery | ||||||
| 12/12/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $23.96 | General |
| Category: ONCOLOGY | ||||||
| 12/06/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $11.17 | General |
| Category: Oncology | ||||||
| 12/05/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $47.87 | General |
| Category: Oncology | ||||||
| 12/04/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological) | Food and Beverage | In-kind items and services | $102.15 | General |
| Category: ONCOLOGY | ||||||
| 12/03/2024 | GlaxoSmithKline, LLC. | ZEJULA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,800.00 | General |
| Category: ONCOLOGY | ||||||
| 11/21/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $22.67 | General |
| Category: ONCOLOGY | ||||||
| 11/14/2024 | Genmab U.S., Inc. | Tivdak (Drug) | Food and Beverage | In-kind items and services | $23.82 | General |
| Category: Oncology | ||||||
| 11/13/2024 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $13.18 | General |
| Category: Oncology | ||||||
| 11/12/2024 | Davol Inc. | — | Honoraria | Cash or cash equivalent | $5,000.00 | General |
| 11/08/2024 | Davol Inc. | ARISTA AH FlexiTip (Device) | Travel and Lodging | In-kind items and services | $184.37 | General |
| Category: Surgery | ||||||
| 11/07/2024 | Davol Inc. | ARISTA AH FlexiTip (Device) | Travel and Lodging | In-kind items and services | $589.62 | General |
| Category: Surgery | ||||||
| 11/06/2024 | Davol Inc. | ARISTA AH FlexiTip (Device) | Food and Beverage | In-kind items and services | $128.18 | General |
| Category: Surgery | ||||||
| 11/06/2024 | Davol Inc. | ARISTA AH FlexiTip (Device) | Food and Beverage | In-kind items and services | $105.08 | General |
| Category: Surgery | ||||||
| 11/01/2024 | Davol Inc. | ARISTA AH FlexiTip (Device) | Travel and Lodging | In-kind items and services | $236.71 | General |
| Category: Surgery | ||||||
| 10/31/2024 | Davol Inc. | ARISTA AH FlexiTip (Device) | Travel and Lodging | In-kind items and services | $216.61 | General |
| Category: Surgery | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A PHASE 2 STUDY OF PREXASERTIB IN PLATINUM-RESISTANT OR REFRACTORY RECURRENT OVARIAN CANCER | Eli Lilly and Company | $9,209 | 2 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 208 | 291 | $93,370 | $32,822 |
| 2022 | 5 | 248 | 341 | $124,408 | $40,122 |
| 2021 | 8 | 347 | 480 | $206,015 | $63,754 |
| 2020 | 9 | 332 | 482 | $161,839 | $46,916 |
Total Patients
1,135
Total Services
1,594
Medicare Billing
$183,615
Procedure Codes
27
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 59 | 110 | $23,650 | $11,157 | 47.2% |
| 58571 | Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, 250.0 g or less | Facility | 2023 | 13 | 13 | $40,794 | $9,101 | 22.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 66 | 90 | $13,680 | $6,450 | 47.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 33 | 33 | $10,791 | $4,065 | 37.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 37 | 45 | $4,455 | $2,049 | 46.0% |
| 58571 | Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, 250.0 g or less | Facility | 2022 | 20 | 20 | $62,760 | $11,999 | 19.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 56 | 101 | $21,715 | $10,715 | 49.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 58 | 58 | $18,966 | $7,725 | 40.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 58 | 93 | $14,136 | $6,788 | 48.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 56 | 69 | $6,831 | $2,896 | 42.4% |
| 58571 | Abdominal removal of uterus (250 grams or less) with removal of tubes and/or ovaries using an endoscope | Facility | 2021 | 30 | 30 | $94,140 | $20,517 | 21.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 76 | 170 | $36,609 | $18,517 | 50.6% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 57 | 57 | $18,639 | $7,545 | 40.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 72 | 96 | $14,644 | $6,760 | 46.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 68 | 83 | $8,256 | $3,854 | 46.7% |
| 38570 | Removal of abdominal cavity lymph nodes using an endoscope | Facility | 2021 | 13 | 13 | $21,203 | $2,613 | 12.3% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 17 | 17 | $6,630 | $2,407 | 36.3% |
| 38900 | Lymph node imaging during surgery | Facility | 2021 | 14 | 14 | $5,894 | $1,541 | 26.1% |
| 58571 | Abdominal removal of uterus (250 grams or less) with removal of tubes and/or ovaries using an endoscope | Facility | 2020 | 18 | 18 | $56,484 | $13,076 | 23.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 77 | 127 | $19,304 | $7,600 | 39.4% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 43 | 74 | $15,910 | $6,450 | 40.5% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Facility | 2020 | 48 | 48 | $15,696 | $6,126 | 39.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 98 | 147 | $14,553 | $5,428 | 37.3% |
| 38571 | Removal of total lymph nodes of both sides of pelvis using an endoscope | Facility | 2020 | 11 | 11 | $27,027 | $3,593 | 13.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 13 | 33 | $4,587 | $1,933 | 42.1% |
About Dr. Kristopher Lybarger, D.O
Dr. Kristopher Lybarger, D.O is a Obstetrics & Gynecology healthcare provider based in Kansas City, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/20/2008. The National Provider Identifier (NPI) number assigned to this provider is 1013172022.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kristopher Lybarger, D.O has received a total of $837,856 in payments from pharmaceutical and medical device companies, with $187,524 received in 2024. These payments were reported across 1,098 transactions from 39 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($346,224).
As a Medicare-enrolled provider, Lybarger has provided services to 1,135 Medicare beneficiaries, totaling 1,594 services with total Medicare billing of $183,615. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Ad
Practice Information
- Specialty Obstetrics & Gynecology
- Other Specialties Gynecologic Oncology, Obstetrics & Gynecology
- Location Kansas City, MO
- Active Since 07/20/2008
- Last Updated 01/27/2022
- Taxonomy Code 207V00000X
- Entity Type Individual
- NPI Number 1013172022
Products in Payments
- ZEJULA (Drug) $276,005
- Rubraca (Drug) $80,867
- JEMPERLI (Biological) $80,093
- ARISTA AH FlexiTip (Device) $53,658
- TIVDAK (Biological) $24,515
- Tivdak (Drug) $16,290
- Da Vinci Surgical System (Device) $12,999
- ARISTA AH FLEXITIP (Device) $9,188
- SURGIFLO Hemostatic Matrix (Device) $8,080
- Elahere (Biological) $6,552
- TIVDAK (Drug) $5,283
- myChoice CDx (Device) $4,949
- MYRISK (Device) $2,374
- LYNPARZA (Drug) $1,965
- MYCHOICE CDX (Device) $1,754
- XPOVIO (Drug) $1,043
- VOYANT (Device) $968.20
- Progel (Device) $785.00
- KEYTRUDA (Biological) $706.84
- Phasix Mesh (Device) $347.31
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Obstetrics & Gynecology Doctors in Kansas City
Dr. Amy Carter, Do, DO
Obstetrics & Gynecology — Payments: $49,799
Obstetrics & Gynecology $49,799
Dr. Austin Findley, Md, MD
Obstetrics & Gynecology — Payments: $26,239
Obstetrics & Gynecology $26,239
Erin Carey, M.d, M.D
Obstetrics & Gynecology — Payments: $18,847
Obstetrics & Gynecology $18,847
Dr. Madhuri Reddy, Md, MD
Obstetrics & Gynecology — Payments: $17,476
Obstetrics & Gynecology $17,476
Ms. Julie Strickland, M.d, M.D
Obstetrics & Gynecology — Payments: $12,055
Obstetrics & Gynecology $12,055
Lori Kramer, Md, MD
Obstetrics & Gynecology — Payments: $11,791
Obstetrics & Gynecology $11,791